Bioenvision's IPO

Bioenvision raised a round of funding on October 09, 2006. Investors include Public.

Bioenvision is a biopharmaceutical company engaged in the development and distribution of drugs to treat cancer. Bioenvision has the opportunity to emerge into an oncology-focused pharmaceutical compa…

Articles about Bioenvision's IPO: